Coeptis Therapeutics Holdings, Inc. (COEP) Stock Grade

About Coeptis Therapeutics Holdings, Inc.'s fundamentals

Coeptis Therapeutics is a small-cap software services company with a market capitalization of $38.6 million that reported zero revenue growth year-over-year. The company posted a substantial net loss in its latest annual statement, resulting in a negative net margin of -874.3%, indicating it spent significantly more than any revenue it generated. With no dividend yield and an inability to calculate standard profitability metrics like P/E ratio and return on equity due to its loss position, the company is currently unprofitable.